Easy Stress Relief by EZH2

被引：1

作者：

Prasanth, Supriya G. ^{[1
]}

Prasanth, Kannanganattu V. ^{[1
]}

机构：

[1] Univ Illinois, Dept Cell & Dev Biol, 601 South Goodwin Ave, Urbana, IL 61801 USA

来源：

CELL | 2016年 / 167卷 / 07期

基金：

美国国家科学基金会;

关键词：

RNA-POLYMERASE-II; NONCODING RNAS; B2; RNA; TRANSCRIPTION; GENOME;

D O I：

10.1016/j.cell.2016.11.051

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

While we are beginning to appreciate the cellular roles played by long noncoding RNAs, the function of transcripts emerging from repetitive genomic regions remains enigmatic. In this issue, Zovoilis et al. report that the polycomb protein EZH2, upon heat shock, facilitates transcription of stressresponsive genes by inducing the degradation of the transcriptional repressor B2 repeat RNA.

引用

页码：1678 / 1680

页数：4

共 50 条

[41] EZH2 in normal and malignant hematopoiesis
Lund, K.
Adams, P. D.
Copland, M.
LEUKEMIA, 2014, 28 (01) : 44 - 49
[42] No Easy Way Out for EZH2: Its Pleiotropic, Noncanonical Effects on Gene Regulation and Cellular Function
Wang, Jun
Wang, Gang Greg
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (24) : 1 - 16
[43] Finding an easy way to harmonize: a review of advances in clinical research and combination strategies of EZH2 inhibitors
Li, Chen
Wang, Yan
Gong, Yueqing
Zhang, Tengrui
Huang, Jiaqi
Tan, Zhen
Xue, Lixiang
CLINICAL EPIGENETICS, 2021, 13 (01)
[44] Finding an easy way to harmonize: a review of advances in clinical research and combination strategies of EZH2 inhibitors
Chen Li
Yan Wang
Yueqing Gong
Tengrui Zhang
Jiaqi Huang
Zhen Tan
Lixiang Xue
Clinical Epigenetics, 2021, 13
[45] EZH2 MUTATION IN FOLLICULAR LYMPHOMA
O' Riain, C.
Smith, P.
Clear, A.
Wrench, D.
Gupta, M.
Boedoer, C.
Matolcsy, A.
Calaminici, M.
Ouentmeier, H.
Drexler, H.
Young, B.
Gribben, J.
Lister, A.
Fitzgibbon, J.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 167 - 167
[46] The noncanonical role of EZH2 in cancer
Huang, Jinhua
Gou, Hongwei
Yao, Jia
Yi, Kaining
Jin, Zhigang
Matsuoka, Masao
Zhao, Tiejun
CANCER SCIENCE, 2021, 112 (04) : 1376 - 1382
[47] Underexpression of EZH2 in Myelodysplastic Syndromes
Wei, Yue
Cabrero, Monica
Jia, Yu
Zheng, Hong
Yang, Hui
Fang, Zhihong
Bohannan, Zach
Garcia-Manero, Guillermo
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S231 - S231
[48] Regulation of Tumor Angiogenesis by EZH2
Lu, Chunhua
Han, Hee Dong
Mangala, Lingegowda S.
Ali-Fehmi, Rouba
Newton, Christopher S.
Ozbun, Laurent
Armaiz-Pena, Guillermo N.
Hu, Wei
Stone, Rebecca L.
Munkarah, Adnan
Ravoori, Murali K.
Shahzad, Mian M. K.
Lee, Jeong-Won
Mora, Edna
Langley, Robert R.
Carroll, Amy R.
Matsuo, Koji
Spannuth, Whitney A.
Schmandt, Rosemarie
Jennings, Nicholas B.
Goodman, Blake W.
Jaffe, Robert B.
Nick, Alpa M.
Kim, Hye Sun
Guven, Eylem Ozturk
Chen, Ya-Huey
Li, Long-Yuan
Hsu, Ming-Chuan
Coleman, Robert L.
Calin, George A.
Denkbas, Emir B.
Lim, Jae Yun
Lee, Ju-Seog
Kundra, Vikas
Birrer, Michael J.
Hung, Mien-Chie
Lopez-Berestein, Gabriel
Sood, Anil K.
CANCER CELL, 2010, 18 (02) : 185 - 197
[49] Abstract PR09: EZH2 inhibitors reveal broad EZH2 dependencies in multiple myeloma
Arora, Shilpi
Williamson, Kaylyn
Balasubramanian, Srividya
Busby, Jennifer
Garapaty-Rao, Shivani
Hatton, Charlie
Sivanandhan, Dhanalakshmi
Bryant, Barbara
Normant, Emmanuel
Trojer, Patrick
CANCER RESEARCH, 2016, 76
[50] Easy or Not-The Advances of EZH2 in Regulating T Cell Development, Differentiation, and Activation in Antitumor Immunity
Huang, Jiaqi
Zhang, Jie
Guo, Zhengyang
Li, Chen
Tan, Zhen
Wang, Junjie
Yang, Jianling
Xue, Lixiang
FRONTIERS IN IMMUNOLOGY, 2021, 12

← 1 2 3 4 5 →